8-K: SANUWAVE Health Announces Board Resignation and New Director Appointment

SANUWAVE Health, Inc. announced the resignation of director A. Michael Stolarski and the appointment of Gregory Bazar to its Board of Directors, effective May 27, 2025.

Summary

• A. Michael Stolarski resigned from SANUWAVE Health, Inc.'s Board of Directors, effective May 27, 2025.
• His resignation was explicitly stated not to be a result of any disagreement between him and the Company, its management, the Board, or any committee.
• Gregory Bazar was appointed to the Board, effective May 27, 2025, to fill the vacancy created by Mr. Stolarski's resignation.
• Mr. Bazar will serve as a director until the 2025 annual meeting of stockholders and until his successor is elected and qualified.
• Mr. Bazar was also appointed to serve as a member of the Compensation Committee of the Board.
• In connection with his appointment, Mr. Bazar received a grant of 41,333 stock options at an exercise price of $27.97 per share, with a ten-year term, vesting in 12 equal installments on each quarterly anniversary of the grant date.
• Additionally, Mr. Bazar will receive quarterly grants of fully vested stock options with a value equal to $20,000, using the Black Scholes valuation on the grant date, as per the Company's director compensation plan.

Sentiment

Score: 7

Explanation: The document reports a routine board change with no stated disagreements, indicating a smooth transition and continuity in corporate governance. The compensation details for the new director are standard.

Positives

• The resignation of A. Michael Stolarski was explicitly stated not to be a result of any disagreement with the Company, indicating a smooth and amicable transition.
• The prompt appointment of Gregory Bazar ensures continuity and maintains the full composition of the Board of Directors.
• Mr. Bazar's appointment to the Compensation Committee strengthens corporate governance in this critical area.
• The document states that Mr. Bazar does not have an interest in any related person transactions, which is positive for corporate governance and transparency.

Future Outlook

The document indicates that Gregory Bazar will serve as a director until the 2025 annual meeting of stockholders and until his successor is elected and qualified.

Management Comments

• "A. Michael Stolarski, a member of the Board of Directors... notified the Company of his decision to resign from the Board, effective May 27, 2025."
• "Mr. Stolarskis resignation is not a result of any disagreement between him and the Company, its management, the Board or any committee of the Board."
• "To fill the vacancy resulting from Mr. Stolarskis resignation, the Board appointed Gregory Bazar to the Board, effective as of May 27, 2025."

Industry Context

This announcement is a routine corporate governance update regarding board composition, common across all industries, and does not directly reflect broader industry trends or competitive dynamics.

Management Changes

Corporate Governance

Related Party Transactions

• Mr. Bazar does not have an interest in any related person transactions (as defined in Item 404(a) of Regulation S-K) with the Company.

Stakeholder Impact

• Shareholders: Board continuity and the appointment of a new director are generally positive for governance stability. The compensation structure for the new director, involving stock options, aligns his interests with shareholders.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Gregory Bazar will serve as a director until the 2025 annual meeting of stockholders.
• A successor for Mr. Bazar will be elected and qualified at or after the 2025 annual meeting.

Key Dates

Recommendation

Keywords

SANUWAVE Health, SNWV, Board of Directors, Director Resignation, Director Appointment, Corporate Governance, Compensation Committee, Stock Options